COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study
Abstract
:1. Introduction
2. Methods
2.1. Study Design
2.2. Population and Setting
2.3. Sample Size and Sampling Procedure
2.4. Data Collection Tool
2.5. Ethics Approval
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Almaghaslah, D.; Alsayari, A. The Effects of the 2019 Novel Coronavirus Disease (COVID-19) Outbreak on Academic Staff Members: A Case Study of a Pharmacy School in Saudi Arabia. Health Policy 2020, 13, 795–802. [Google Scholar] [CrossRef]
- Almaghaslah, D.; Kandasamy, G.; Almanasef, M.; Vasudevan, R.; Chandramohan, S. Review on the coronavirus disease (COVID-19) pandemic: Its outbreak and current status. Int. J. Clin. Pract. 2020, 74, e13637. [Google Scholar] [CrossRef] [PubMed]
- Schwarzinger, M.; Watson, V.; Arwidson, P.; Alla, F.; Luchini, S. COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. Lancet Public Health 2021, 2667, 1–12. [Google Scholar] [CrossRef]
- Al-Mohaithef, M.; Padhi, B.K. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J. Multidiscip. Health 2020, 13, 1657–1663. [Google Scholar] [CrossRef]
- World Health Organization (WHO). Coronavirus Disease (COVID-19): Vaccines. Available online: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey=%7Badgroupsurvey%7D&gclid=Cj0KCQiAvP6ABhCjARIsAH37rbS5A6vxPeHzxZO_lHnlo4S3sZtDQmlPugeE7_GQs8V1syZULBB5DMgaAkn3EALw_wcB (accessed on 8 February 2021).
- The Centre for Disease Control and Prevention (CDC). COVID-19 Vaccination. Available online: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html (accessed on 8 February 2021).
- Food and Drug Administration. COVID-19 Vaccines. Available online: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines (accessed on 9 February 2021).
- Savulescu, J. Good reasons to vaccinate: Mandatory or payment for risk? J. Med. Ethic 2021, 47, 78–85. [Google Scholar] [CrossRef] [PubMed]
- Ministry of Health (MOH). COVID-19 Vaccines. Available online: https://covid19awareness.sa/en/archives/10691 (accessed on 8 February 2021).
- Lawes-Wickwar, S.; Ghio, D.; Tang, M.; Keyworth, C.; Stanescu, S.; Westbrook, J.; Jenkinson, E.; Kassianos, A.; Scanlan, D.; Garnett, N.; et al. A Rapid Systematic Review of Public Responses to Health Messages Encouraging Vaccination against Infectious Diseases in a Pandemic or Epidemic. Vaccines 2021, 9, 72. [Google Scholar] [CrossRef] [PubMed]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021, 27, 225–228. [Google Scholar] [CrossRef] [PubMed]
- Coustasse, A.; Kimble, C.; Maxik, K. COVID-19 and Vaccine Hesitancy. J. Ambul. Care Manag. 2021, 44, 71–75. [Google Scholar] [CrossRef] [PubMed]
- Harapan, H.; Wagner, A.L.; Yufika, A.; Winardi, W.; Anwar, S.; Gan, A.K.; Setiawan, A.M.; Rajamoorthy, Y.; Sofyan, H.; Mudatsir, M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front. Public Health 2020, 8, 381. [Google Scholar] [CrossRef] [PubMed]
- Minisitry of Health (MOH). MOH Announces Rescheduling of COVID-19 Vaccination Due to Supply Delay. Available online: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2021-01-20-010.aspx (accessed on 8 February 2021).
- Lin, Y.; Hu, Z.; Zhao, Q.; Alias, H.; Danaee, M.; Wong, L.P. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLOS Negl. Trop. Dis. 2020, 14, e0008961. [Google Scholar] [CrossRef] [PubMed]
- Lin, C.; Tu, P.; Beitsch, L.M. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines 2020, 9, 16. [Google Scholar] [CrossRef] [PubMed]
- Murphy, J.; Vallières, F.; Bentall, R.P.; Shevlin, M.; McBride, O.; Hartman, T.K.; McKay, R.; Bennett, K.; Mason, L.; Gibson-Miller, J.; et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun. 2021, 12, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Khubchandani, J.; Sharma, S.; Price, J.H.; Wiblishauser, M.J.; Sharma, M.; Webb, F.J. COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. J. Community Health 2021, 46, 270–277. [Google Scholar] [CrossRef] [PubMed]
- Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Marc, G.P.; Moreira, E.D.; Zerbini, C.; et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 2020, 383, 2603–2615. [Google Scholar] [CrossRef] [PubMed]
- Badiani, A.; Patel, J.; Ziolkowski, K.; Nielsen, F. Pfizer: The miracle vaccine for COVID-19? Public Health Pract. 2020, 1, 100061. [Google Scholar] [CrossRef]
- De Kock, J.H.; Latham, H.A.; Leslie, S.J.; Grindle, M.; Munoz, S.A.; Ellis, L.; Polson, R.; O’Malley, C.M. A rapid review of the impact of COVID-19 on the mental health of healthcare workers: Implications for supporting psychological well-being. BMC Public Health 2021, 21, 1–18. [Google Scholar] [CrossRef] [PubMed]
- Alkhamees, A.A.; Alrashed, S.A.; Alzunaydi, A.A.; Almohimeed, A.S.; Aljohani, M.S. The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia. Compr. Psychiatry 2020, 102, 152192. [Google Scholar] [CrossRef] [PubMed]
- Largent, E.A.; Persad, G.; Sangenito, S.; Glickman, A.; Boyle, C.; Emanuel, E.J. US Public Attitudes Toward COVID-19 Vaccine Mandates. JAMA Netw. Open 2020, 3, e2033324. [Google Scholar] [CrossRef] [PubMed]
- Phadke, V.K.; Bednarczyk, R.A.; Salmon, D.A.; Omer, S.B. Association between Vaccine Refusal and Vaccine-Preventable Diseases in the United States. JAMA 2016, 315, 1149–1158. [Google Scholar] [CrossRef] [Green Version]
- Mello, M.M.; Silverman, R.D.; Omer, S.B. Ensuring Uptake of Vaccines against SARS-CoV-2. N. Engl. J. Med. 2020, 383, 1293–1296. [Google Scholar] [CrossRef]
Number | Percent (%) | |
---|---|---|
Age | ||
18–29 | 554 | 64.3 |
30–39 | 240 | 27.9 |
40–49 | 55 | 4.6 |
>50 | 13 | 1.5 |
Gender | ||
female | 470 | 54.5 |
male | 392 | 45.5 |
Education level | ||
High school and below | 280 | 32.5 |
University education and above | 582 | 67.5 |
Chronic conditions such as hypertension or diabetes | ||
Yes | 52 | 6 |
No | 810 | 94 |
Previous COVID-19 infection | ||
Yes | 169 | 19.6 |
No | 693 | 80.4 |
COVID-19 Vaccination history | ||
Yes | 18 | 2.1 |
No | 844 | 97.9 |
Vaccine registration through (Sehaty) app | ||
Yes | 175 | 20.3 |
No | 687 | 79.7 |
Statements | Strongly Disagree | Disagree | Neutral | Agree | Strongly Agree |
---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | n (%) | |
Perceived Severity and Susceptibility | |||||
COVID-19 infection is not serious so I don’t think I should take the vaccine | 248 (29.5) | 222 (26.4) | 210 (25) | 116 (13.8) | 45 (5.4) |
I have had COVID-19 infection and I think I’ve developed immunity against the virus | 311 (36.9) | 229 (27.2) | 180 (21.4) | 76 (9) | 29 (3.4) |
The likelihood of getting COVID-19 infection is low now, numbers are decreasing in Saudi Arabia (January, 2021) | 304 (36.2) | 230 (27.4) | 172 (44.9) | 102 (12.2) | 30 (3.6) |
Statements | Strongly Disagree | Disagree | Neutral | Agree | Strongly Agree |
---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | n (%) | |
Perceived barrier (hesitancy) | |||||
I’m not sure of eligibility and registration process | 228 (27.4) | 213 (25.6) | 209 (25.1) | 158 (18.9) | 24 (2.9) |
I’m not sure of the effectiveness of the vaccination | 137 (16.4) | 122 (14.6) | 160 (19.1) | 266 (31.8) | 152 (18.1) |
I believe that natural immunity is sufficient, and I don’t think I need to take the vaccine | 206 (24.6) | 211 (25.2) | 175 (20.9) | 146 (17.4) | 99 (11.8) |
I’ve heard on social media that the vaccine is not safe as it would contain the COVID-19 virus, so I’m worried about the side effects | 224 (26.7) | 147 (17.5) | 190 (22.7) | 195 (23.3) | 82 (9.8) |
Perceived benefits | |||||
Taking the vaccine would make me less worried about catching COVID-19 | 164 (19.7) | 164 (19.7) | 178 (21.4) | 238 (28.6) | 87 (10.5) |
Vaccination decreases my chance of getting COVID-19 or its complication | 127 (15.2) | 165 (19.8) | 170 (20.4) | 257 (30.8) | 114 (17.2) |
Vaccination would ease the precautionary measures including lock down, quarantine, and travel ban. | 127 (15.2) | 121 (14.5) | 197 (23.6) | 262 (31.4) | 128 (15.3) |
Causes of action | |||||
I will only take the COVID-19 vaccine if I was given adequate information about it | 164 (19.7) | 164 (19.7) | 178 (21.4) | 238 (28.6) | 87 (10.5) |
I will only take the COVID-19 vaccine if the vaccine is taken by many in the public | 127 (15.2) | 165 (19.8) | 170 (20.4) | 257 (30.8) | 114 (17.2) |
I will only take the COVID-19 vaccine if it was made mandatory | 127 (15.2) | 121 (14.5) | 197 (23.6) | 262 (31.4) | 128 (15.3) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Almaghaslah, D.; Alsayari, A.; Kandasamy, G.; Vasudevan, R. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study. Vaccines 2021, 9, 330. https://doi.org/10.3390/vaccines9040330
Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study. Vaccines. 2021; 9(4):330. https://doi.org/10.3390/vaccines9040330
Chicago/Turabian StyleAlmaghaslah, Dalia, Abdulrhman Alsayari, Geetha Kandasamy, and Rajalakshimi Vasudevan. 2021. "COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study" Vaccines 9, no. 4: 330. https://doi.org/10.3390/vaccines9040330